Robert Lechleider's most recent trade in Immunome Inc was a trade of 242,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on July 29, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Immunome Inc | Robert Lechleider | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2025 | 242,000 | 242,000 | - | - | Employee Stock Option (right to buy) | |
| Immunome Inc | Robert Lechleider | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 9.48 per share. | 21 Nov 2024 | 15,805 | 15,805 | - | 9.5 | 149,800 | Common Stock |
| Immunome Inc | Robert Lechleider | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2024 | 200,000 | 200,000 | - | - | Stock option (right to buy) |